Skip to content
OpenCapital
Get started

Revvity RVTY Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies

Veeva Systems logo
Veeva SystemsVEEV
-$262.53M-1,388%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
——
Illumina logo
IlluminaILMN
——
IQVIA logo
IQVIAIQV
——
Roivant Sciences logo
Roivant SciencesROIV
——
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
——

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%—
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's cash provided by (used in) financing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's cash provided by (used in) financing activity, including discontinued operation?
Revvity (RVTY) reported cash provided by (used in) financing activity, including discontinued operation of -$88.9M in Q1 2026.
How has Revvity's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
Revvity's cash provided by (used in) financing activity, including discontinued operation increased by 45.7% year-over-year, from -$163.66M to -$88.9M.
What is the long-term trend for Revvity's cash provided by (used in) financing activity, including discontinued operation?
Over 3 years (2022 to 2025), Revvity's cash provided by (used in) financing activity, including discontinued operation has grown at a 9.0% compound annual growth rate (CAGR), from -$661.8M to -$857.52M.